Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation

NCT01919346 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDIV

Sponsor class

Stopped Based on results from Alexion PROTECT DGF study

Conditions

Delayed Graft Function
Kidney Transplantation
Complement Activity

Interventions

DRUG: Eculizumab
DRUG: Normal Saline

Sponsor

Heeger, Peter, M.D.

Collaborators

[object Object]
[object Object]